CN Stock MarketDetailed Quotes

Beijing Beilu Pharmaceutical (300016)

Watchlist
  • 8.90
  • -0.15-1.66%
Market Closed May 20 15:00 CST
5.18BMarket Cap41.98P/E (TTM)

Beijing Beilu Pharmaceutical (300016) Balance Sheet

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Assets
Current assets
Money funds
-21.19%429.29M
14.75%295.44M
25.03%352.29M
-35.57%304.98M
0.47%544.72M
-65.60%257.46M
-62.95%281.77M
-33.58%473.33M
-17.66%542.18M
-2.39%748.45M
Transactional financial assets
28.13%371.13M
8.26%379.75M
-17.55%343.64M
42.96%396M
11.40%289.65M
--350.77M
1,984.03%416.81M
592.50%277M
44.20%260M
----
Notes receivable and accounts receivable
40.06%238.13M
50.59%265.14M
42.12%222.49M
18.06%217.74M
-0.65%170.03M
-6.62%176.07M
4.69%156.56M
22.84%184.44M
58.04%171.14M
67.35%188.55M
-Notes receivable
-15.77%7.91M
88.84%10.94M
304.25%8.79M
415.72%6.99M
116.99%9.39M
65.12%5.79M
0.73%2.17M
-69.98%1.36M
-35.65%4.33M
-45.73%3.51M
-Accounts receivable
43.32%230.23M
49.28%254.2M
38.42%213.7M
15.11%210.75M
-3.70%160.64M
-7.98%170.28M
4.75%154.38M
25.72%183.08M
64.24%166.81M
74.24%185.04M
Other receivables (including interest and dividends)
48.29%838.94K
18.60%3.11M
-36.32%1.2M
22.90%965.88K
-76.57%565.73K
50.64%2.63M
103.94%1.89M
-22.50%785.9K
90.18%2.42M
-58.26%1.74M
-Other receivable
----
----
----
--965.88K
----
50.64%2.63M
----
----
----
-58.26%1.74M
Advance payment
-51.94%13.88M
49.07%13.54M
-16.03%21.06M
-32.16%9.8M
35.41%28.88M
26.01%9.08M
29.52%25.08M
48.74%14.44M
221.34%21.33M
58.18%7.21M
Inventories
0.38%355.93M
5.98%383.75M
13.53%367.75M
21.23%375.2M
40.84%354.59M
47.88%362.09M
29.40%323.93M
23.50%309.48M
-10.22%251.76M
-11.35%244.86M
Non-current assets due within one year
-59.84%116.88K
-60.27%115.63K
-2.90%114.32K
-8.13%107.03K
--291.01K
--291.01K
--117.73K
--116.5K
----
----
Other current assets
101.99%37.69M
181.42%35.98M
309.90%30.58M
106.84%21.74M
304.59%18.66M
113.59%12.78M
8.67%7.46M
-28.52%10.51M
-66.90%4.61M
-56.18%5.99M
Total current assets
2.82%1.45B
17.56%1.38B
10.34%1.34B
4.44%1.33B
12.28%1.41B
-2.14%1.17B
-1.30%1.21B
5.75%1.27B
0.17%1.25B
1.59%1.2B
Non Current assets
Other equity investment
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
0.00%100K
Other non-current financial assets
15.85%393.09M
15.31%392.09M
-0.27%343.05M
-3.08%337.67M
-3.80%339.31M
-4.23%340.02M
-6.37%344M
-4.90%348.42M
-3.17%352.71M
-1.96%355.05M
Investment real estate
--2.1M
--2.12M
----
----
----
----
----
----
----
----
Long-term equity investment
-5.94%184.36M
-6.21%184.44M
-6.06%185.3M
-6.01%185.86M
-0.52%196M
-2.13%196.64M
-1.70%197.25M
-1.18%197.73M
-0.57%197.03M
0.98%200.92M
Long term receivable account
4.79%1.32M
-8.19%1.31M
-12.34%1.47M
-12.17%1.46M
--1.26M
--1.43M
--1.68M
--1.66M
----
----
Fixed assets
----
----
----
7.29%878.36M
----
18.02%892.07M
----
8.43%818.67M
----
-3.45%755.88M
Constru in process
----
----
----
-7.01%129.92M
----
-36.36%70.26M
----
59.73%139.72M
----
145.39%110.39M
Productive biological assets
-7.36%5.44M
-8.47%5.57M
-3.10%5.7M
-4.91%5.83M
--5.88M
--6.09M
--5.88M
--6.13M
----
----
Intangible assets
-8.82%143.72M
-8.46%147.22M
-7.64%152.07M
-8.70%154.71M
27.71%157.61M
25.26%160.82M
42.81%164.66M
42.39%169.46M
1.44%123.42M
2.63%128.39M
Goodwill
0.00%46.92M
0.00%46.92M
0.00%46.92M
0.00%46.92M
--46.92M
--46.92M
47.46%46.92M
47.46%46.92M
----
----
Long deferred expense
11.73%25.12M
1.32%25.27M
4.89%21.88M
40.55%22.88M
34.34%22.48M
45.07%24.94M
36.00%20.86M
3.63%16.28M
2.52%16.74M
16.27%17.2M
Deferred tax assets
-3.91%35.62M
-10.49%37M
12.73%36.73M
22.63%40.66M
6.78%37.07M
-0.12%41.33M
-25.00%32.58M
-19.02%33.15M
-5.21%34.72M
5.24%41.38M
Usufruct assets
149.47%2.6M
-64.45%2.71M
-66.45%2.82M
-69.79%2.93M
-88.73%1.04M
-23.51%7.61M
-21.90%8.4M
-14.60%9.69M
-21.57%9.24M
-20.80%9.95M
Other non current assets
-25.16%20.17M
-48.58%9.31M
172.90%36M
536.06%61.81M
3.84%26.95M
435.86%18.11M
180.14%13.19M
95.73%9.72M
364.33%25.96M
-42.03%3.38M
Total non current assets
10.71%1.99B
9.10%1.97B
4.76%1.88B
3.98%1.87B
11.33%1.8B
11.32%1.81B
9.48%1.8B
10.09%1.8B
-0.61%1.62B
-1.10%1.62B
Total assets
7.25%3.44B
12.43%3.35B
7.01%3.22B
4.17%3.2B
11.74%3.21B
5.61%2.98B
4.86%3.01B
8.25%3.07B
-0.27%2.87B
0.03%2.82B
Liabilities
Current liabilities
Short term loan
31.83%283.6M
54.95%216.96M
2.63%195.31M
-34.25%160.02M
12.01%215.12M
-20.25%140.02M
18.81%190.3M
186.27%243.38M
86.39%192.06M
63.15%175.56M
Transactional financial liabilities
1.72%11.73M
9.43%12.18M
6.50%12.33M
9.67%12.43M
8.96%11.53M
-0.31%11.13M
--11.58M
--11.33M
--10.58M
--11.17M
Notes payable and accounts payable
32.77%196.31M
25.14%214.38M
22.67%192.12M
14.17%185.19M
34.58%147.86M
48.81%171.32M
48.97%156.61M
21.65%162.21M
-13.29%109.87M
-18.30%115.12M
-Notes payable
4.84%70.08M
66.86%98.31M
34.70%75.91M
6.36%72.41M
68.98%66.84M
193.61%58.92M
41.13%56.35M
50.01%68.08M
-25.11%39.56M
-63.37%20.07M
-Accounts payable
55.81%126.23M
3.26%116.06M
15.92%116.22M
19.81%112.78M
15.23%81.01M
18.24%112.4M
53.77%100.26M
7.01%94.13M
-4.84%70.31M
10.38%95.06M
Contract liabilities
4.36%6.32M
-24.01%6.66M
13.91%6.01M
157.52%8.18M
119.89%6.06M
335.00%8.76M
-34.31%5.28M
-67.92%3.18M
-60.56%2.75M
-54.72%2.01M
Salaries payable
2.21%14.65M
3.76%26.91M
-17.39%13.13M
-6.00%14.69M
4.91%14.33M
-2.60%25.93M
4.78%15.9M
37.35%15.63M
53.10%13.66M
26.16%26.62M
Taxs payable
86.99%18.76M
275.95%17.77M
334.58%17.56M
94.02%22.09M
134.84%10.03M
57.78%4.73M
-54.42%4.04M
24.08%11.38M
-25.56%4.27M
-48.14%3M
Other payable (including interest and dividends)
40.05%47.62M
7.92%27.97M
7.97%25.7M
35.56%33.51M
138.52%34M
173.29%25.91M
120.26%23.8M
50.48%24.72M
164.66%14.26M
1.65%9.48M
-Other payable
----
----
----
35.56%33.51M
----
173.29%25.91M
----
50.48%24.72M
----
1.65%9.48M
Non current liabilities due within one year
-79.16%23.45M
-23.89%48.44M
256.73%140.2M
326.86%145.43M
453.74%112.52M
296.40%63.65M
107.48%39.3M
90.24%34.07M
-31.44%20.32M
21.27%16.06M
Other current liabilities
-76.35%2.46M
-17.14%3.13M
54.21%674.13K
1,444.42%1.97M
3,973.50%10.42M
2,498.02%3.78M
292.46%437.14K
0.71%127.64K
-8.40%255.75K
-43.70%145.58K
Total current liabilities
7.66%604.9M
26.18%574.39M
34.83%603.04M
15.31%583.5M
52.67%561.87M
26.74%455.23M
36.67%447.25M
78.64%506.02M
27.08%368.03M
18.67%359.17M
Current liabilities
Long term loan
34.97%265.89M
146.08%248.79M
8.54%154M
9.86%166M
29.14%197M
-22.20%101.1M
8.31%141.89M
10.90%151.1M
5.62%152.55M
44.74%129.95M
Bonds payable
----
----
----
2.40%492.01M
7.73%507.88M
7.90%499.14M
8.06%489.87M
8.20%480.5M
8.34%471.44M
8.46%462.6M
Deferred tax liabilities
17.30%80.14M
13.49%80.5M
2.11%67.63M
-2.98%66.88M
13.66%68.32M
13.53%70.93M
14.47%66.24M
18.24%68.93M
8.51%60.11M
6.69%62.48M
Long term deferred income
-18.20%22.3M
45.60%24.52M
121.81%26.15M
124.83%27.04M
113.34%27.26M
43.45%16.84M
42.90%11.79M
35.52%12.02M
29.42%12.78M
48.82%11.74M
Lease liabilities
593.57%1.75M
-55.02%2.16M
-64.94%1.97M
-69.64%1.94M
-95.53%252.48K
-32.99%4.8M
-28.75%5.63M
-25.97%6.38M
-39.34%5.65M
-28.18%7.17M
Total non current liabilities
-53.78%370.07M
-48.62%355.97M
-65.09%249.75M
4.86%753.86M
13.98%800.71M
2.80%692.82M
8.67%715.42M
9.57%718.93M
7.40%702.53M
13.70%673.94M
Total liabilities
-28.45%974.97M
-18.96%930.36M
-26.65%852.8M
9.18%1.34B
27.28%1.36B
11.12%1.15B
17.97%1.16B
30.40%1.22B
13.44%1.07B
15.38%1.03B
Shareholders equity
Paid-in capital
14.42%562.87M
14.42%562.87M
14.42%562.87M
0.67%495.21M
0.00%491.95M
0.00%491.95M
0.00%491.94M
0.00%491.94M
0.00%491.94M
-0.00%491.93M
Other equity instruments
----
----
----
-5.42%106.49M
-0.02%112.57M
-0.02%112.57M
-15.00%112.59M
-15.00%112.59M
-15.00%112.59M
-15.00%112.59M
Capital reserve funds
415.67%697.91M
415.68%697.91M
416.11%697.91M
19.71%161.88M
0.09%135.34M
0.09%135.34M
0.00%135.22M
0.01%135.22M
0.01%135.22M
-0.06%135.22M
Surplus reserve funds
7.41%164.76M
7.41%164.76M
3.81%153.4M
3.81%153.4M
3.81%153.4M
3.81%153.4M
0.00%147.76M
0.00%147.76M
0.00%147.76M
0.00%147.76M
Retained profit
11.07%874.8M
7.34%829.82M
0.33%792.63M
-0.78%778.42M
1.42%787.59M
1.05%773.05M
-5.81%789.99M
-7.30%784.57M
-12.13%776.56M
-12.19%765.03M
Other composite income
0.00%-2.43M
0.00%-2.43M
0.00%-2.43M
0.00%-2.43M
0.00%-2.43M
0.00%-2.43M
0.00%-2.43M
0.00%-2.43M
0.00%-2.43M
0.00%-2.43M
Specific reserves
31.84%6.45M
55.59%5.79M
98.13%6.69M
128.40%5.88M
205.85%4.89M
632.42%3.72M
408.00%3.38M
359.05%2.58M
207.46%1.6M
109.82%508.25K
Shareholders equity without minority interests
36.90%2.3B
35.45%2.26B
31.73%2.21B
1.59%1.7B
1.21%1.68B
1.03%1.67B
-3.78%1.68B
-4.55%1.67B
-7.04%1.66B
-7.08%1.65B
Minority interests
-0.66%159.93M
-2.13%158.45M
-6.86%157.92M
-6.52%159.44M
18.33%161M
19.31%161.9M
20.13%169.55M
19.65%170.57M
-6.02%136.06M
-7.62%135.69M
Total shareholder equity
33.62%2.46B
32.12%2.42B
28.19%2.37B
0.84%1.86B
2.50%1.84B
2.42%1.83B
-1.99%1.85B
-2.73%1.84B
-6.96%1.8B
-7.12%1.79B
Total liabilityies and equity
7.25%3.44B
12.43%3.35B
7.01%3.22B
4.17%3.2B
11.74%3.21B
5.61%2.98B
4.86%3.01B
8.25%3.07B
-0.27%2.87B
0.03%2.82B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
PwC China (Special General Partnership)
--
--
--
PwC China (Special General Partnership)
--
--
--
PwC China (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Assets
Current assets
Money funds -21.19%429.29M14.75%295.44M25.03%352.29M-35.57%304.98M0.47%544.72M-65.60%257.46M-62.95%281.77M-33.58%473.33M-17.66%542.18M-2.39%748.45M
Transactional financial assets 28.13%371.13M8.26%379.75M-17.55%343.64M42.96%396M11.40%289.65M--350.77M1,984.03%416.81M592.50%277M44.20%260M----
Notes receivable and accounts receivable 40.06%238.13M50.59%265.14M42.12%222.49M18.06%217.74M-0.65%170.03M-6.62%176.07M4.69%156.56M22.84%184.44M58.04%171.14M67.35%188.55M
-Notes receivable -15.77%7.91M88.84%10.94M304.25%8.79M415.72%6.99M116.99%9.39M65.12%5.79M0.73%2.17M-69.98%1.36M-35.65%4.33M-45.73%3.51M
-Accounts receivable 43.32%230.23M49.28%254.2M38.42%213.7M15.11%210.75M-3.70%160.64M-7.98%170.28M4.75%154.38M25.72%183.08M64.24%166.81M74.24%185.04M
Other receivables (including interest and dividends) 48.29%838.94K18.60%3.11M-36.32%1.2M22.90%965.88K-76.57%565.73K50.64%2.63M103.94%1.89M-22.50%785.9K90.18%2.42M-58.26%1.74M
-Other receivable --------------965.88K----50.64%2.63M-------------58.26%1.74M
Advance payment -51.94%13.88M49.07%13.54M-16.03%21.06M-32.16%9.8M35.41%28.88M26.01%9.08M29.52%25.08M48.74%14.44M221.34%21.33M58.18%7.21M
Inventories 0.38%355.93M5.98%383.75M13.53%367.75M21.23%375.2M40.84%354.59M47.88%362.09M29.40%323.93M23.50%309.48M-10.22%251.76M-11.35%244.86M
Non-current assets due within one year -59.84%116.88K-60.27%115.63K-2.90%114.32K-8.13%107.03K--291.01K--291.01K--117.73K--116.5K--------
Other current assets 101.99%37.69M181.42%35.98M309.90%30.58M106.84%21.74M304.59%18.66M113.59%12.78M8.67%7.46M-28.52%10.51M-66.90%4.61M-56.18%5.99M
Total current assets 2.82%1.45B17.56%1.38B10.34%1.34B4.44%1.33B12.28%1.41B-2.14%1.17B-1.30%1.21B5.75%1.27B0.17%1.25B1.59%1.2B
Non Current assets
Other equity investment 0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K0.00%100K
Other non-current financial assets 15.85%393.09M15.31%392.09M-0.27%343.05M-3.08%337.67M-3.80%339.31M-4.23%340.02M-6.37%344M-4.90%348.42M-3.17%352.71M-1.96%355.05M
Investment real estate --2.1M--2.12M--------------------------------
Long-term equity investment -5.94%184.36M-6.21%184.44M-6.06%185.3M-6.01%185.86M-0.52%196M-2.13%196.64M-1.70%197.25M-1.18%197.73M-0.57%197.03M0.98%200.92M
Long term receivable account 4.79%1.32M-8.19%1.31M-12.34%1.47M-12.17%1.46M--1.26M--1.43M--1.68M--1.66M--------
Fixed assets ------------7.29%878.36M----18.02%892.07M----8.43%818.67M-----3.45%755.88M
Constru in process -------------7.01%129.92M-----36.36%70.26M----59.73%139.72M----145.39%110.39M
Productive biological assets -7.36%5.44M-8.47%5.57M-3.10%5.7M-4.91%5.83M--5.88M--6.09M--5.88M--6.13M--------
Intangible assets -8.82%143.72M-8.46%147.22M-7.64%152.07M-8.70%154.71M27.71%157.61M25.26%160.82M42.81%164.66M42.39%169.46M1.44%123.42M2.63%128.39M
Goodwill 0.00%46.92M0.00%46.92M0.00%46.92M0.00%46.92M--46.92M--46.92M47.46%46.92M47.46%46.92M--------
Long deferred expense 11.73%25.12M1.32%25.27M4.89%21.88M40.55%22.88M34.34%22.48M45.07%24.94M36.00%20.86M3.63%16.28M2.52%16.74M16.27%17.2M
Deferred tax assets -3.91%35.62M-10.49%37M12.73%36.73M22.63%40.66M6.78%37.07M-0.12%41.33M-25.00%32.58M-19.02%33.15M-5.21%34.72M5.24%41.38M
Usufruct assets 149.47%2.6M-64.45%2.71M-66.45%2.82M-69.79%2.93M-88.73%1.04M-23.51%7.61M-21.90%8.4M-14.60%9.69M-21.57%9.24M-20.80%9.95M
Other non current assets -25.16%20.17M-48.58%9.31M172.90%36M536.06%61.81M3.84%26.95M435.86%18.11M180.14%13.19M95.73%9.72M364.33%25.96M-42.03%3.38M
Total non current assets 10.71%1.99B9.10%1.97B4.76%1.88B3.98%1.87B11.33%1.8B11.32%1.81B9.48%1.8B10.09%1.8B-0.61%1.62B-1.10%1.62B
Total assets 7.25%3.44B12.43%3.35B7.01%3.22B4.17%3.2B11.74%3.21B5.61%2.98B4.86%3.01B8.25%3.07B-0.27%2.87B0.03%2.82B
Liabilities
Current liabilities
Short term loan 31.83%283.6M54.95%216.96M2.63%195.31M-34.25%160.02M12.01%215.12M-20.25%140.02M18.81%190.3M186.27%243.38M86.39%192.06M63.15%175.56M
Transactional financial liabilities 1.72%11.73M9.43%12.18M6.50%12.33M9.67%12.43M8.96%11.53M-0.31%11.13M--11.58M--11.33M--10.58M--11.17M
Notes payable and accounts payable 32.77%196.31M25.14%214.38M22.67%192.12M14.17%185.19M34.58%147.86M48.81%171.32M48.97%156.61M21.65%162.21M-13.29%109.87M-18.30%115.12M
-Notes payable 4.84%70.08M66.86%98.31M34.70%75.91M6.36%72.41M68.98%66.84M193.61%58.92M41.13%56.35M50.01%68.08M-25.11%39.56M-63.37%20.07M
-Accounts payable 55.81%126.23M3.26%116.06M15.92%116.22M19.81%112.78M15.23%81.01M18.24%112.4M53.77%100.26M7.01%94.13M-4.84%70.31M10.38%95.06M
Contract liabilities 4.36%6.32M-24.01%6.66M13.91%6.01M157.52%8.18M119.89%6.06M335.00%8.76M-34.31%5.28M-67.92%3.18M-60.56%2.75M-54.72%2.01M
Salaries payable 2.21%14.65M3.76%26.91M-17.39%13.13M-6.00%14.69M4.91%14.33M-2.60%25.93M4.78%15.9M37.35%15.63M53.10%13.66M26.16%26.62M
Taxs payable 86.99%18.76M275.95%17.77M334.58%17.56M94.02%22.09M134.84%10.03M57.78%4.73M-54.42%4.04M24.08%11.38M-25.56%4.27M-48.14%3M
Other payable (including interest and dividends) 40.05%47.62M7.92%27.97M7.97%25.7M35.56%33.51M138.52%34M173.29%25.91M120.26%23.8M50.48%24.72M164.66%14.26M1.65%9.48M
-Other payable ------------35.56%33.51M----173.29%25.91M----50.48%24.72M----1.65%9.48M
Non current liabilities due within one year -79.16%23.45M-23.89%48.44M256.73%140.2M326.86%145.43M453.74%112.52M296.40%63.65M107.48%39.3M90.24%34.07M-31.44%20.32M21.27%16.06M
Other current liabilities -76.35%2.46M-17.14%3.13M54.21%674.13K1,444.42%1.97M3,973.50%10.42M2,498.02%3.78M292.46%437.14K0.71%127.64K-8.40%255.75K-43.70%145.58K
Total current liabilities 7.66%604.9M26.18%574.39M34.83%603.04M15.31%583.5M52.67%561.87M26.74%455.23M36.67%447.25M78.64%506.02M27.08%368.03M18.67%359.17M
Current liabilities
Long term loan 34.97%265.89M146.08%248.79M8.54%154M9.86%166M29.14%197M-22.20%101.1M8.31%141.89M10.90%151.1M5.62%152.55M44.74%129.95M
Bonds payable ------------2.40%492.01M7.73%507.88M7.90%499.14M8.06%489.87M8.20%480.5M8.34%471.44M8.46%462.6M
Deferred tax liabilities 17.30%80.14M13.49%80.5M2.11%67.63M-2.98%66.88M13.66%68.32M13.53%70.93M14.47%66.24M18.24%68.93M8.51%60.11M6.69%62.48M
Long term deferred income -18.20%22.3M45.60%24.52M121.81%26.15M124.83%27.04M113.34%27.26M43.45%16.84M42.90%11.79M35.52%12.02M29.42%12.78M48.82%11.74M
Lease liabilities 593.57%1.75M-55.02%2.16M-64.94%1.97M-69.64%1.94M-95.53%252.48K-32.99%4.8M-28.75%5.63M-25.97%6.38M-39.34%5.65M-28.18%7.17M
Total non current liabilities -53.78%370.07M-48.62%355.97M-65.09%249.75M4.86%753.86M13.98%800.71M2.80%692.82M8.67%715.42M9.57%718.93M7.40%702.53M13.70%673.94M
Total liabilities -28.45%974.97M-18.96%930.36M-26.65%852.8M9.18%1.34B27.28%1.36B11.12%1.15B17.97%1.16B30.40%1.22B13.44%1.07B15.38%1.03B
Shareholders equity
Paid-in capital 14.42%562.87M14.42%562.87M14.42%562.87M0.67%495.21M0.00%491.95M0.00%491.95M0.00%491.94M0.00%491.94M0.00%491.94M-0.00%491.93M
Other equity instruments -------------5.42%106.49M-0.02%112.57M-0.02%112.57M-15.00%112.59M-15.00%112.59M-15.00%112.59M-15.00%112.59M
Capital reserve funds 415.67%697.91M415.68%697.91M416.11%697.91M19.71%161.88M0.09%135.34M0.09%135.34M0.00%135.22M0.01%135.22M0.01%135.22M-0.06%135.22M
Surplus reserve funds 7.41%164.76M7.41%164.76M3.81%153.4M3.81%153.4M3.81%153.4M3.81%153.4M0.00%147.76M0.00%147.76M0.00%147.76M0.00%147.76M
Retained profit 11.07%874.8M7.34%829.82M0.33%792.63M-0.78%778.42M1.42%787.59M1.05%773.05M-5.81%789.99M-7.30%784.57M-12.13%776.56M-12.19%765.03M
Other composite income 0.00%-2.43M0.00%-2.43M0.00%-2.43M0.00%-2.43M0.00%-2.43M0.00%-2.43M0.00%-2.43M0.00%-2.43M0.00%-2.43M0.00%-2.43M
Specific reserves 31.84%6.45M55.59%5.79M98.13%6.69M128.40%5.88M205.85%4.89M632.42%3.72M408.00%3.38M359.05%2.58M207.46%1.6M109.82%508.25K
Shareholders equity without minority interests 36.90%2.3B35.45%2.26B31.73%2.21B1.59%1.7B1.21%1.68B1.03%1.67B-3.78%1.68B-4.55%1.67B-7.04%1.66B-7.08%1.65B
Minority interests -0.66%159.93M-2.13%158.45M-6.86%157.92M-6.52%159.44M18.33%161M19.31%161.9M20.13%169.55M19.65%170.57M-6.02%136.06M-7.62%135.69M
Total shareholder equity 33.62%2.46B32.12%2.42B28.19%2.37B0.84%1.86B2.50%1.84B2.42%1.83B-1.99%1.85B-2.73%1.84B-6.96%1.8B-7.12%1.79B
Total liabilityies and equity 7.25%3.44B12.43%3.35B7.01%3.22B4.17%3.2B11.74%3.21B5.61%2.98B4.86%3.01B8.25%3.07B-0.27%2.87B0.03%2.82B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --PwC China (Special General Partnership)------PwC China (Special General Partnership)------PwC China (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More